Jaguar Health, Inc. (JAGX) › Operating IncomeJaguar Health, Inc. (JAGX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$8.32M2015: -$12.45M2016: -$13.59M2017: -$34.25M2018: -$30.82M2019: -$28.95M2020: -$26.65M2021: -$40.71M2022: -$34.41M2023: -$34.29M2024: -$30.83M2025: -$45.91M-$45.91M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$45.91M-48.9%2024-$30.83M+10.1%2023-$34.29M+0.4%2022-$34.41M+15.5%2021-$40.71M-52.8%2020-$26.65M+7.9%2019-$28.95M+6.1%2018-$30.82M+10.0%2017-$34.25M-152.1%2016-$13.59M-9.2%2015-$12.45M-49.7%2014-$8.32M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share